DMD and Duchenne muscular dystrophy: Taking advantage of this nature, AO-mediated exon skipping aims to convert out-of-frame mRNAs to in-frame ones, so that shortened yet partially functional dystrophin can be produced in DMD patient muscles and help delay disease progression.